Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-12-14
DOI
10.3389/fneur.2022.1016377
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies
- (2022) Panagiotis T. Diamantopoulos et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
- (2022) Nora Möhn et al. JOURNAL OF NEUROLOGY
- The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee
- (2021) Stuart G. Tangye et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Improving risk‐stratification of natalizumab‐associated PML
- (2021) Bastian Tugemann et al. Annals of Clinical and Translational Neurology
- Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses
- (2021) Valarmathy Murugaiah et al. Viruses-Basel
- Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
- (2021) Nicolás Fissolo et al. Neurology-Neuroimmunology & Neuroinflammation
- Evidence, in Context: A Regulatory Perspective on Pharmacogenetics
- (2021) Michael Pacanowski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions
- (2021) Charles L Bennett et al. Lancet Haematology
- Changes in John Cunningham virus index in Multiple Sclerosis patients treated with different disease-modifying therapies
- (2021) Eleonora Sgarlata et al. Current Neuropharmacology
- Late-Onset Progressive Multifocal Leukoencephalopathy (PML) and Lymphoma in a 65-Year-Old Patient with XIAP Deficiency
- (2021) Julie Seguier et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Tipping the balance: intricate roles of the complement system in disease and therapy
- (2021) Richard B. Pouw et al. Seminars in Immunopathology
- Pediatric Hemophagocytic Lymphohistiocytosis (HLH)
- (2020) Scott Canna et al. BLOOD
- Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
- (2020) Stuart G. Tangye et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non‐responders
- (2020) Xiaodong Yang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The genetics of macrophage activation syndrome
- (2020) Grant S. Schulert et al. GENES AND IMMUNITY
- Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations
- (2020) Tiziana Lorenzini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The mutational constraint spectrum quantified from variation in 141,456 humans
- (2020) Konrad J. Karczewski et al. NATURE
- Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
- (2020) Peggy S. Eis et al. Frontiers in Neurology
- The imitation game: a viral strategy to subvert the complement system
- (2020) Palak Agrawal et al. FEBS LETTERS
- Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod
- (2020) Mitsuru Watanabe et al. Journal of Neuroinflammation
- Long-Term Survival after Progressive Multifocal Leukoencephalopathy in a Patient with Primary Immune Deficiency and NFKB1 Mutation
- (2020) Emke Maréchal et al. JOURNAL OF CLINICAL IMMUNOLOGY
- B cell depletion therapies in autoimmune disease: advances and mechanistic insights
- (2020) Dennis S. W. Lee et al. NATURE REVIEWS DRUG DISCOVERY
- Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease
- (2020) Irene Cortese et al. Nature Reviews Neurology
- Viral CD229 (Ly9) homologs as new manipulators of host immunity
- (2019) Ana Angulo et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients
- (2019) Gloria Dalla Costa et al. ANNALS OF NEUROLOGY
- Three cases of non-carryover fingolimod-PML
- (2019) Jin Nakahara et al. Neurology-Neuroimmunology & Neuroinflammation
- Novel Polyomaviruses in Mammals from Multiple Orders and Reassessment of Polyomavirus Evolution and Taxonomy
- (2019) Ehlers et al. Viruses-Basel
- Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration
- (2018) Shinji Aoyama et al. JOURNAL OF NEUROLOGY
- Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned
- (2018) Eugene O Major et al. LANCET NEUROLOGY
- Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients
- (2018) Yasuo Oshima et al. Multiple Sclerosis Journal
- Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients
- (2018) Yasuo Oshima et al. Multiple Sclerosis Journal
- Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird’s Eye View
- (2018) Elizabeth A. Mills et al. Frontiers in Immunology
- Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients
- (2018) Ursela Baber et al. JOURNAL OF NEUROLOGY
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
- (2018) Mitja Mitrovič et al. CELL
- Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies
- (2018) Jérôme Hadjadj et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies
- (2017) Pei-Ran Ho et al. LANCET NEUROLOGY
- Natalizumab-associated PML
- (2017) Nicholas Schwab et al. NEUROLOGY
- HLA-A*24:02 as a common risk factor for antiepileptic drug–induced cutaneous adverse reactions
- (2017) Yi-Wu Shi et al. NEUROLOGY
- A taxonomy update for the family Polyomaviridae
- (2016) Sébastien Calvignac-Spencer et al. ARCHIVES OF VIROLOGY
- Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature
- (2016) Christa S. Zerbe et al. CLINICAL INFECTIOUS DISEASES
- Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA’s adverse event reporting system
- (2016) Dennis W. Raisch et al. Expert Opinion On Drug Safety
- Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies
- (2016) E C M Tonk et al. PHARMACOGENOMICS JOURNAL
- Responses to Microbial Challenges by SLAMF Receptors
- (2016) Boaz Job van Driel et al. Frontiers in Immunology
- Genetic Diagnosis Using Whole Exome Sequencing in Common Variable Immunodeficiency
- (2016) Patrick Maffucci et al. Frontiers in Immunology
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency
- (2015) Karin R. Engelhardt et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Is There a (Host) Genetic Predisposition to Progressive Multifocal Leukoencephalopathy?
- (2015) Eli Hatchwell Frontiers in Immunology
- Identification of a Novel Mutation in MAGT1 and Progressive Multifocal Leucoencephalopathy in a 58-Year-Old Man with XMEN Disease
- (2014) Fatima Dhalla et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Whole Genome Sequencing Reveals a Chromosome 9p Deletion Causing DOCK8 Deficiency in an Adult Diagnosed with Hyper IgE Syndrome Who Developed Progressive Multifocal Leukoencephalopathy
- (2014) Aaron G. Day-Williams et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Sorting out the risks in progressive multifocal leukoencephalopathy
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning
- (2014) Elena Sieni et al. Frontiers in Immunology
- Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis
- (2013) Elizabeth P. Sampaio et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section
- (2013) J. R. Berger et al. NEUROLOGY
- HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
- (2013) E Genin et al. PHARMACOGENOMICS JOURNAL
- Complement genetics, deficiencies, and disease associations
- (2012) Karine R. Mayilyan Protein & Cell
- Toxic epidermal necrolysis and Stevens-Johnson syndrome
- (2011) Thomas Harr et al. Orphanet Journal of Rare Diseases
- Assessing Long-Term Drug Safety: Lessons (Re) Learned from Raptiva
- (2010) Nicole M. Seminara et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now